Search results
101 The Fox staple DJ Slacker dies from cancer complications, family announces
Kansas City Star via AOL· 6 days agoClassic rock station 101 The Fox announced that Brian Adams, known as Slacker to listeners, died...
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
NBC 10 - FOX 14 Monroe· 19 hours agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML ...
...Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute ...
Morningstar· 6 days ago“We are delighted to safely progress through the second, higher dose cohort to reach an important study milestone for the United States Food and Drug Administration...
Moleculin's acute myeloid leukemia treatment gets EMA's orphan drug designation
Seeking Alpha· 6 days agoMoleculin Biotech's Annamycin receives Orphan Drug Designation from the European Medicines Agency for AML treatment, expanding its potential market reach.
Potential new treatment strategy for aggressive leukemia
Medical Xpress· 5 days agoIn findings published in Nature Cancer, researchers reveal that blocking these oxygen-sensing enzymes can significantly halt acute myeloid leukemia ...
FDA grants breakthrough status for Kura Oncology's AML drug candicate By Investing.com
Investing.com· 2 days agoFood and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to its drug...
Coffee Memorial Blood Center seeks platelet donations amid low supply
KAMR Amarillo· 9 hours agoOfficials with the Coffee Memorial Blood Center asked community members to donate blood platelets...
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress· 8 hours agoA study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute ...
NBC 17 Raleigh· 6 days ago– Next-generation non-cardiotoxic anthracycline Annamycin with notable signs of clinical efficacy in AML in combination with Cytarabine achieves preliminary CRc rate of 60% in 2nd line AML subjects ...
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Zacks via Yahoo Finance· 4 days agoBio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its...